Original Research ARTICLE
Flexible low-dose GnRH-Antagonist Protocol is Effective in Patients with Sufficient Ovarian Reserve in IVF
- 1Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, China
- 2Shanghai Key Laboratory of Reproductive Medicine, Shanghai Jiao Tong University, China
Gonadotropin-releasing hormone antagonist (GnRH-ant) has been shown to negatively influence endometrial receptivity. Reducing the GnRH-ant dose during controlled ovarian stimulation (COS) when using a GnRH-ant protocol may be beneficial to embryo implantation. However, whether or not the minimum daily GnRH-ant dose should be individualized remains uncertain. In this retrospective study, we aimed to elucidate the feasibility and effectiveness of moderately reducing the daily GnRH-ant dose to 0.125 mg, and then adjusting the dose to 0.25 mg based on subsequent luteinizing hormone (LH) levels. Of the 434 patients analyzed in this study, 209 received our new flexible low-dose GnRH-ant protocol (Group 1) and 225 received a conventional GnRH-ant protocol with a fixed daily dose of 0.25 mg (Group 2). Furthermore, 105 and 114 cycles from groups 1 and 2 received fresh embryo transfer. In Group 1, 30 patients whose dose of 0.125 mg GnRH-ant was adjusted according to their LH levels and 179 patients who received consistently low doses were further divided into subgroups 1 and 2, respectively. Neither the number of retrieved oocytes and available embryos nor the implantation rate, clinical pregnancy rate, and ongoing pregnancy rate significantly differed between the two groups. However, GnRH-ant dose and stimulation duration were much lower and shorter in Group 1 than in Group 2 (P < 0.05). Subgroup 1 exhibited higher basal follicle-stimulating hormone (FSH) and lower antral follicle count (AFC) than subgroup 2 significantly. The number of retrieved oocytes and available embryos were lower in subgroup 1 than in subgroup 2 (6.83 ± 3.28 vs. 11.83 ± 4.82, 2.93 ± 1.86 vs. 4.99 ± 3.46, respectively, p < 0.05), while more cancelled cycles for pre-ovulation occurred in subgroup 1 than in subgroup 2 (3/30 vs. 1/179, p < 0.05). The results showed that the flexible low-dose GnRH-ant protocol was as effective as the conventional fixed-dose GnRH-ant protocol with 0.25 mg per day for most patients with normal ovarian reserve. This retrospective analysis and the small sample size are the main limitations of this study, and a large sample RCT trail will be carried out in future.
Keywords: flexible low-dose GnRH-ant protocol, Cetrorelix, IVF, LH surge, GnRH antagonist
Received: 07 Sep 2018;
Accepted: 06 Dec 2018.
Edited by:Leif J. Bungum, IVI Middle East Fertility Clinic LLC, United Arab Emirates
Reviewed by:Hakan Yarali, Anatolia IVF Center, Turkey
Himanshu Arora, University of Miami, United States
Marie Louise M. Wissing, Region Zealand, Denmark
Copyright: © 2018 Zhang, Xia, Xu, Chen, Jin, Zhang and Xu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Prof. Jun a. Zhang, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China, firstname.lastname@example.org
Dr. Fang b. Xu, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China, email@example.com